GlassScriptPhysician profile
Melissa Grier
NPI 1861484420
$3,933.18
in general payments reported to CMS, 2019-2025
22 companies · $61.79 in 2025
The $61.79 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $720 · 2020: $893 · 2021: $1,149 · 2022: $630 · 2023: $435 · 2024: $44.61 · 2025: $61.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,805.50 | 2019-2023 | |
| Olympus Corporation of The Americas | $1,001.33 | 2019-2020 | |
| Myovant Sciences INC. | $216.39 | 2021-2022 | |
| Evofem Biosciences, INC. | $171.69 | 2020-2022 | |
| Organon LLC | $125.00 | 2023 | |
| Therapeuticsmd, INC. | $106.87 | 2021-2022 | |
| Pfizer INC. | $64.26 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $62.15 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $60.27 | 2021-2023 | |
| Allergan, INC. | $53.84 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.63 | 2021-2025 | |
| Ascend Therapeutics US, LLC | $39.83 | 2019-2023 | |
| Intuitive Surgical, INC. | $32.73 | 2019 | |
| Hologic Sales and Service, LLC | $20.88 | 2021 | |
| Lilly USA, LLC | $20.45 | 2025 | Mounjaro, Zepbound |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.34 | 2023 | Gardasil 9 |
| Roche Diagnostics Corporation | $17.88 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $17.02 | 2023 | Vivjoa |
| Coopersurgical, INC. | $15.44 | 2019 | |
| Exeltis, USA INC. | $14.78 | 2019 | |
| Shield Therapeutics INC | $14.77 | 2022 | |
| Avion Pharmaceuticals | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Grier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.